Univest
Univest
  • Markets
  • Invesco India Liquid Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    Invesco India Liquid Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Invesco India Liquid Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Balanced Advantage Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Kunal Singla
    • Category: Mutual Funds
    No Comments
    ITI Balanced Advantage Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Balanced Advantage Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • Invesco India Money Market Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    Invesco India Money Market Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Invesco India Money Market Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • Invesco India Medium Duration Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    Invesco India Medium Duration Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Invesco India Medium Duration Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Pharma and Healthcare Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    ITI Pharma and Healthcare Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Pharma and Healthcare Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Small Cap Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    ITI Small Cap Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Small Cap Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Value Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Kunal Singla
    • Category: Mutual Funds
    No Comments
    ITI Value Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Value Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • Invesco India Credit Risk Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    Invesco India Credit Risk Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Invesco India Credit Risk Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Ultra Short Term Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Lakshit Sharma
    • Category: Mutual Funds
    No Comments
    ITI Ultra Short Term Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Ultra Short Term Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • ITI Focused Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    • August 20, 2026
    • Posted by: Kunal Singla
    • Category: Mutual Funds
    No Comments
    ITI Focused Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026

    Complete review of Iti Focused Fund with latest NAV, all plans and options, expense ratio and investor suitability.

    read more
  • 1
  • …
  • 453
  • 454
  • 455
  • 456
  • 457
  • …
  • 2,723